Cargando…
A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome
OBJECTIVE: CHF5633 (Chiesi Farmaceutici S.p.A., Parma, Italy) is the first fully synthetic surfactant enriched by peptide analogues of two human surfactant proteins. We planned to assess safety and tolerability of CHF5633 and explore preliminary efficacy. DESIGN: Multicentre cohort study. PATIENTS:...
Autores principales: | Sweet, David G, Turner, Mark A, Straňák, Zbyněk, Plavka, Richard, Clarke, Paul, Stenson, Ben J, Singer, Dominique, Goelz, Rangmar, Fabbri, Laura, Varoli, Guido, Piccinno, Annalisa, Santoro, Debora, Speer, Christian P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Archives of Disease in Childhood
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739829/ https://www.ncbi.nlm.nih.gov/pubmed/28465315 http://dx.doi.org/10.1136/archdischild-2017-312722 |
Ejemplares similares
-
Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4(+) Lymphocytes
por: Fehrholz, Markus, et al.
Publicado: (2016) -
Impact of synthetic surfactant CHF5633 with SP‐B and SP‐C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome
por: Mikolka, Pavol, et al.
Publicado: (2021) -
Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14(+) Monocytes
por: Glaser, Kirsten, et al.
Publicado: (2016) -
Lung Surfactant Protein A (SP-A) Interactions with Model Lung Surfactant Lipids and an SP-B Fragment
por: Sarker, Muzaddid, et al.
Publicado: (2011) -
International survey on diagnosis and management of hypotension in extremely preterm babies
por: Stranak, Zbynek, et al.
Publicado: (2014)